{
  "image_filename": "figure_p2_mrg_det_1_000.png",
  "image_path": "Liu_et_al.__2024_/extracted/figures/figure_p2_mrg_det_1_000.png",
  "image_type": "Figure",
  "page_number": 2,
  "block_id": "mrg_det_1_000",
  "claim_id": "claim_000",
  "claim": "Flublok ensures identical antigenic match with WHO- and FDA-selected flu strains.",
  "supports_claim": false,
  "explanation": "CONSORT flow diagram illustrating Year 1 (2018\u20132019) enrollment and randomization of 723 participants into four vaccine arms (ccIIV4, RIV, Fluzone IIV4, Fluarix IIV4) with age breakdowns and visit completion, followed by Year 2 re-enrollment and re-randomization of participants into various vaccine sequences. does not support the claim because the image only depicts participant enrollment, randomization, and visit completion; it provides no data on antigenic matching to WHO- or FDA-selected influenza strains.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "CONSORT flow diagram illustrating Year 1 (2018\u20132019) enrollment and randomization of 723 participants into four vaccine arms (ccIIV4, RIV, Fluzone IIV4, Fluarix IIV4) with age breakdowns and visit completion, followed by Year 2 re-enrollment and re-randomization of participants into various vaccine sequences.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the image only depicts participant enrollment, randomization, and visit completion; it provides no data on antigenic matching to WHO- or FDA-selected influenza strains.",
    "confidence_notes": null
  }
}